<DOC>
	<DOCNO>NCT00697255</DOCNO>
	<brief_summary>The primary objective trial evaluate whether corifollitropin alfa ( Org 36286 ) regimen apply single repeat dose corifollitropin alfa follow low daily dose Human Chorion Gonadotropin ( hCG ) recombinant Follicular Stimulating Hormone ( recFSH ) induce monofollicular growth ( one follicle ≥18 mm follicle ≥15 mm day bolus injection hCG ) woman WHO group II anovulatory infertility .</brief_summary>
	<brief_title>A Phase 2 Trial Evaluate Corifollitropin Alfa ( Org 36286 ) , Followed Low Daily Dose hCG Recombinant FSH Can Induce Monofollicular Growth Women With WHO Group II Anovulatory Infertility ( P05693 )</brief_title>
	<detailed_description>This trial include two separate stage ( Ia+Ib II ) . Stage Ia open-label uncontrolled small cohort woman ( n=5 ) explore whether intended dose regimen corifollitropin alfa follow daily low dose recFSH provide appropriate response eligible participant meet inclusion none exclusion criterion . Stage Ib open-label uncontrolled small cohort woman ( n=5 ) explore whether intended dose regimen corifollitropin alfa follow daily low dose hCG provide appropriate response eligible participant meet inclusion none exclusion criterion . Stage II open-label randomized ( n=40 ) evaluate whether intend dose regimen corifollitropin alfa follow low dose FSH ( n=20 ) hCG ( n=20 ) provide appropriate response eligible participant meet inclusion none exclusion criterion .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>Oligomenorrhea ( average cycle length ≥35 day &lt; 6 month ) Amenorrhea ( average cycle length ≥6 month ) Body Mass Index ≥18 ≤30 kg/m^2 Normal serum FSH level normal estradiol level screen Progestagen induce withdrawal bleeding Age ≥18 year ≤39 year time signing informed consent Willing able sign inform consent History current ovarian cyst enlarge ovary relate polycystic ovarian syndrome ( PCOS ) History current tumor ovary , breast , uterus , pituitary hypothalamus Less 2 ovary Undiagnosed vaginal bleeding Any ovarian and/or abdominal abnormality interfere ultrasound examination Malformations sexual organ incompatible pregnancy Pregnancy lactation Abnormal serum endocrinology level base screen sample Any clinically relevant abnormal laboratory value base screen sample Alcohol drug abuse within 12 month precede signing informed consent Hypersensitivity substances corifollitropin alfa Hypersensitivity hCG/ Puregon® component Previous use corifollitropin alfa Use investigational drug 90 day screen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Pharmacological effect drug</keyword>
	<keyword>Hormones</keyword>
	<keyword>Hormone Substitutes Hormone Antagonists</keyword>
	<keyword>Pharmacological Actions</keyword>
	<keyword>Monofollicular growth</keyword>
	<keyword>Randomized</keyword>
	<keyword>Open-label</keyword>
	<keyword>Active-controlled</keyword>
</DOC>